Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar pchop123 (76.53) Submitted: 8/11/2012 7:15:54 PM : Outperform Start Price: $1.40 CBLI Score: +20.60

opportunity after recent overeaction

Featured Broker Partners


Advertisement